ArticleBlood advances2019
Validation of genetic associations with acute GVHD and nonrelapse mortality in DISCOVeRY-BMT.
Abstract readLetterComment
In one paragraph
Article in Blood advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Leveraging Hematopoietic Cell Transplant Data and Biorepository Resources at the Center for International Blood and Marrow Transplant Research to Improve Patient Outcomes.Transplantation and cellular therapy · 2024Article
- Associations of minor histocompatibility antigens with outcomes following allogeneic hematopoietic cell transplantation.American journal of hematology · 2023Article
- Shared graft-versus-leukemia minor histocompatibility antigens in DISCOVeRY-BMT.Blood advances · 2023Article
- Novel genetic variants associated with mortality after unrelated donor allogeneic hematopoietic cell transplantation.EClinicalMedicine · 2021Article
- Neither Donor nor Recipient Mitochondrial Haplotypes Are Associated with Unrelated Donor Transplant Outcomes: A Validation Study from the CIBMTR.Transplantation and cellular therapy · 2021Article
- Post-haematopoietic cell transplantation outcomes: why ST2 became a 'golden nugget' biomarker.British journal of haematology · 2021Review
- Biomarkers for Allogeneic HCT Outcomes.Frontiers in immunology · 2020Review
Corrections and comments
- Comment on
Authors and funding
21 authors.
Hancong TangPharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, OH.
Theresa HahnDepartment of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY.
Ezgi KaraesmenPharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, OH.ORCID 0000-0002-0881-7424
Abbas A RizviPharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, OH.
Junke WangPharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, OH.
Sophie PaczesnyDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, IN.ORCID 0000-0001-5571-2775
Tao WangCenter for International Blood and Marrow Transplant Research, Department of Medicine, and.
Leah PreusPharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, OH.
Qianqian ZhuDepartment of Biostatistics, Roswell Park Comprehensive Cancer Center, Buffalo, NY.ORCID 0000-0003-2516-6675
Yiwen WangPharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, OH.
Christopher A HaimanDepartment of Preventive Medicine, University of Southern California, Los Angeles, CA.
Daniel StramDepartment of Preventive Medicine, University of Southern California, Los Angeles, CA.
Loreall PoolerDepartment of Preventive Medicine, University of Southern California, Los Angeles, CA.ORCID 0000-0001-5388-6640
Xin ShengDepartment of Preventive Medicine, University of Southern California, Los Angeles, CA.ORCID 0000-0002-6844-2740
David Van Den BergDepartment of Preventive Medicine, University of Southern California, Los Angeles, CA.
Guy BrockDepartment of Biomedical Informatics, The Ohio State University, Columbus, OH.
Amy WebbDepartment of Biomedical Informatics, The Ohio State University, Columbus, OH.
Marcelo C PasquiniCenter for International Blood and Marrow Transplant Research, Department of Medicine, and.ORCID 0000-0003-1579-2293
Philip L McCarthyDepartment of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY.ORCID 0000-0002-9577-3879
Stephen R SpellmanCenter for International Blood and Marrow Transplant Research, National Marrow Donor Program, Minneapolis, MN; and.
Lara E Sucheston-CampbellPharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, OH.
Funding
Data Resource for Analyzing Blood &Marrow TransplantsU24CA076518 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI Amy M Moskop, Bronwen Shaw · 1998 to 2026
$105.2MEasy-to-read Informed Consent for HCT Clinical TrialsU10HL069294 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI HOROWITZ, MARY MARESCA · 2011 to 2016
$43.8MGenetic susceptibility to unrelated donor stem cell transplant-related mortalityR01HL102278 · NHLBI · ROSWELL PARK CANCER INSTITUTE CORP · PI HAHN, THERESA E, SUCHESTON-CAMPBELL, LARA · 2010 to 2013
$5.0MTranslating Novel Drug-Targetable Biomarkers to Treat Graft versus Host DiseaseR01CA168814 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI PACZESNY, SOPHIE · 2013 to 2024
$3.0MBridging Pediatric and Adult Biomarkers of Graft-Versus-Host-DiseaseR01HD074587 · NICHD · INDIANA UNIVERSITY INDIANAPOLIS · PI PACZESNY, SOPHIE, RENBARGER, JAMIE L · 2013 to 2017
$2.4MProject 2: Biomarkers of endothelial dysfunction in pediatric patients receiving high intensity chemotherapy/irradiationU54HD090215 · NICHD · INDIANA UNIVERSITY INDIANAPOLIS · PI PACZESNY, SOPHIE · 2016 to 2018
$2.3MGenetic susceptibility to acute lymphocytic and myeloid leukemiaR03CA188733 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI HAHN, THERESA E, SUCHESTON-CAMPBELL, LARA · 2015 to 2016
$176kNCI NIH HHS R01 CA168814NCI NIH HHS R03 CA188733NCI NIH HHS U24 CA076518NHLBI NIH HHS R01 HL102278NHLBI NIH HHS U10 HL069294NICHD NIH HHS R01 HD074587NICHD NIH HHS U54 HD090215
Abstract
PubMed holds no abstract for this paper.
Indexed as
Graft vs Host DiseaseHematopoietic Stem Cell TransplantationBone Marrow TransplantationCytokinesHumansPolymorphism, GeneticCytokines
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.